 A between-subjects double-blind trial will compare daily outpatient treatment using a narrow 468 nm, 27 nm half-peak bandwidth LED light source GoLITETM to a broad 400-700 nm wavelength LED-generated light housed in an identical device in 24 seasonally-depressed adults. Dependent variables will be severity of depression and extent of adverse effects. 